Fluorescence polarization serology for veterinary brucellosis: anti-O-polysaccharide antibody biology, assay comparability, and decision-rule validation

Fluorescence polarization assays (FPAs) rapidly detect antibodies to the O-polysaccharide (OPS) of smooth Brucella lipopolysaccharide for veterinary brucellosis surveillance. Interpretation depends on both antibody biology and the measurement procedure. This focused narrative review links the biological target and operational measurand to the reported result, assay classification, and diagnostic interpretation. It draws on antibody and tracer research, veterinary validation studies, and a human multistage-screening example to examine assay comparison and decision-rule validation. OPS-FPA measures the host immunological response, whereas PCR detects Brucella DNA. Smooth vaccination and cross-reactive carbohydrate antigens limit the infection specificity of OPS reactivity. Camel evidence illustrates model-dependent accuracy estimates, and experimental elk findings show that antibody responses can decline despite persistent infection. The proposed risk-based framework matches validation evidence to the change assessed. Documented minor changes warrant focused verification and/or paired comparability studies proportionate to risk; changes in result definition or scale require justified bridging and decision-rule reassessment; and changes in biological target, host, specimen matrix, or intended use require diagnostic revalidation in the new setting. Exact unit conversion alone does not create a new assay. Priorities are decision-boundary specimens, well-characterized reference panels, uncertainty assessment, and independent evaluation of the complete serological–molecular pathway. Selected-subgroup accuracy and assay agreement alone cannot establish the performance of a deployed diagnostic strategy.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2026-11-17
DOI
https://doi.org/10.3389/fmicb.2026.2029235
Primary Topic
Brucella: diagnosis, epidemiology, treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fluorescence polarization serology for veterinary brucellosis: anti-O-polysaccharide antibody biology, assay comparability, and decision-rule validation

Luyu Mao, Shuya Yang, Jinlong Ma, Yongli Guo et al.
1 links
Frontiers in Microbiology
Brucella: diagnosis, epidemiology, treatment
article

Fluorescence polarization serology for veterinary brucellosis: anti-O-polysaccharide antibody biology, assay comparability, and decision-rule validation

Luyu Mao, Shuya Yang, Jinlong Ma, Yongli Guo, Yuncai Cui, Mingchun Gao
article en

Abstract

Fluorescence polarization assays (FPAs) rapidly detect antibodies to the O-polysaccharide (OPS) of smooth Brucella lipopolysaccharide for veterinary brucellosis surveillance. Interpretation depends on both antibody biology and the measurement procedure. This focused narrative review links the biological target and operational measurand to the reported result, assay classification, and diagnostic interpretation. It draws on antibody and tracer research, veterinary validation studies, and a human multistage-screening example to examine assay comparison and decision-rule validation. OPS-FPA measures the host immunological response, whereas PCR detects Brucella DNA. Smooth vaccination and cross-reactive carbohydrate antigens limit the infection specificity of OPS reactivity. Camel evidence illustrates model-dependent accuracy estimates, and experimental elk findings show that antibody responses can decline despite persistent infection. The proposed risk-based framework matches validation evidence to the change assessed. Documented minor changes warrant focused verification and/or paired comparability studies proportionate to risk; changes in result definition or scale require justified bridging and decision-rule reassessment; and changes in biological target, host, specimen matrix, or intended use require diagnostic revalidation in the new setting. Exact unit conversion alone does not create a new assay. Priorities are decision-boundary specimens, well-characterized reference panels, uncertainty assessment, and independent evaluation of the complete serological–molecular pathway. Selected-subgroup accuracy and assay agreement alone cannot establish the performance of a deployed diagnostic strategy.

Frontiers in MicrobiologyVol. 17
Harbin Medical University (CN), Northeast Agricultural University (CN)
Good health and well-being
Brucella: diagnosis, epidemiology, treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon